MVA-BN Smallpox Vaccine

Preferred Label : MVA-BN Smallpox Vaccine;

NCIt synonyms : MVA Smallpox Vaccine; Modified Vaccinia Ankara Smallpox Vaccine; Modified Vaccinia Ankara - Bavarian Nordic Smallpox Vaccine;

NCIt related terms : VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN;

NCIt definition : A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.;

UNII : TU8J357395;

CAS number : 1026718-04-6;

Drug name : Imvamune; Imvanex; JYNNEOS;

NCI Metathesaurus CUI : CL1407321;

Details

Origin ID

C173552;

UMLS CUI

C5420259;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic [MeSH Supplementary Concept]
chemical_or_drug_affects_cell_type_or_tissue
- Cytotoxic T-Lymphocyte [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Immunopotentiation [NCIt concept]
- T-Cell Activation [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients